USFDA issues Form 483 with four observations to Dr Reddy’s API unit
The inspection was conducted from May 30, 2024 to June 7, 2024, it added. 1 min read Last Updated :
Continue readingThe Number One Finance & Business Blog!
The inspection was conducted from May 30, 2024 to June 7, 2024, it added. 1 min read Last Updated :
Continue readingVedanta on Thursday said ICRA has assigned A1+ rating to the company’s Rs 2,500-crore commercial paper, citing multiple positives. ICRA
Continue readingPharma major Dr Reddy’s Laboratories on Friday announced it has entered a licensing agreement with US-based company Pharmazz to
Continue readingIndian pharmaceutical firm Dr Reddy’s Laboratories beat estimates for third-quarter profit on Tuesday, helped by strong performance in its
Continue readingDr. Reddy’s recently also became the first Indian pharma company to join the World Economic Forum’s (WEF) 1t.org community.
Continue readingDr Reddy’s Laboratories (DRL) said on Wednesday that it has entered into an exclusive collaboration with US-based Coya Therapeutics
Continue readingDr Reddy’s Laboratories on Wednesday said its unit has inked a licensing agreement with Coya Therapeutics Inc to develop
Continue reading